Wordt geladen...
P01.095 The use of TTFields for newly diagnosed GBM patients in Germany in routine clinical care (TIGER: TTFields in Germany in routine clinical care)
BACKGROUND: Glioblastoma (GBM) is the most common malignant primary brain tumor. Survival in GBM has remained essentially unchanged since 2005 despite numerous clinical Phase 3 trials conducted. Tumor treating fields (TTFields) are low-intensity, intermediate frequency, alternating electric fields t...
Bewaard in:
| Gepubliceerd in: | Neuro Oncol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144436/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.137 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|